Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
AIDS Research and Human Retroviruses
|
January 11, 2008
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients
Veronique Nussenblatt, Mary McLaughlin, Catherine A Rehm, et al.
Plos One
|
March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
Martin Lagging, Galia Askarieh, Francesco Negro, et al.
Journal of Hepatology
|
February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
Vincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
BMC Gastroenterology
|
February 2, 2012
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
Geert Bezemer, Arthur R Van Gool, Elke Verheij-Hart, et al.
Allergy
|
January 21, 2022
Differential effects of lung inflammation on insulin resistance in humans and mice
Ruth Karlina, Claudia Flexeder, Stephanie Musiol, et al.
The Journal of Infectious Diseases
|
September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Ana I Romero, Martin Lagging, Johan Westin, et al.
Allergy
|
June 5, 2020
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Urszula Radzikowska, Mei Ding, Ge Tan, et al.
Gastroenterology
|
March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signaling
Jordan J Feld, Glen A Lutchman, Theo Heller, et al.
Plos One
|
February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection
Jonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana I Romero, Johan Westin, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
AIDS Research and Human Retroviruses
|
January 11, 2008
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients
Veronique Nussenblatt, Mary McLaughlin, Catherine A Rehm, et al.
Plos One
|
March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
Martin Lagging, Galia Askarieh, Francesco Negro, et al.
Journal of Hepatology
|
February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
Vincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
BMC Gastroenterology
|
February 2, 2012
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
Geert Bezemer, Arthur R Van Gool, Elke Verheij-Hart, et al.
Allergy
|
January 21, 2022
Differential effects of lung inflammation on insulin resistance in humans and mice
Ruth Karlina, Claudia Flexeder, Stephanie Musiol, et al.
The Journal of Infectious Diseases
|
September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Ana I Romero, Martin Lagging, Johan Westin, et al.
Allergy
|
June 5, 2020
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Urszula Radzikowska, Mei Ding, Ge Tan, et al.
Gastroenterology
|
March 23, 2010
Ribavirin improves early responses to peginterferon through improved interferon signaling
Jordan J Feld, Glen A Lutchman, Theo Heller, et al.
Plos One
|
February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection
Jonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana I Romero, Johan Westin, et al.
Page
of 9